NUTRIBAND INC. Research and Development Expense
NUTRIBAND INC. (NTRB) reported Research and Development Expense of $322.19 thousand for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-04
- NUTRIBAND INC. research and development expense for the quarter ending 2026-07-31 was $322.19K, a 42.73% decline year-over-year.
- NUTRIBAND INC. research and development expense for the quarter ending 2026-04-30 was $247.26K, a 63.82% decline year-over-year.
- NUTRIBAND INC. research and development expense for the quarter ending 2026-01-31 was $188.04K, a 61.61% decline year-over-year.
- NUTRIBAND INC. research and development expense for the quarter ending 2025-10-31 was $457.11K, a 48.10% decline year-over-year.
- NUTRIBAND INC. research and development expense for fiscal 2026 was $1.89M, a 39.37% decline from fiscal 2025.
- NUTRIBAND INC. research and development expense for fiscal 2025 was $3.12M, a 59.10% increase from fiscal 2024.
- NUTRIBAND INC. research and development expense for fiscal 2024 was $1.96M, a 99.59% increase from fiscal 2023.
- NUTRIBAND INC. research and development expense for fiscal 2023 was $982.23K, a 138.76% increase from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-07-31 | $322.19K 10-Q · filed 2026-09-04 | $569.46K 10-Q · filed 2026-09-04 | $757.49K derived: sum of 3 quarters · filed 2026-09-04 | $1.21M derived: sum of 4 quarters · filed 2026-09-04 |
| 2026-04-30 | $247.26K 10-Q · filed 2026-06-11 | $435.30K derived: sum of 2 quarters · filed 2026-06-11 | $892.41K derived: sum of 3 quarters · filed 2026-06-11 | $1.45M derived: sum of 4 quarters · filed 2026-09-04 |
| 2026-01-31 | $188.04K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-29 | $645.15K derived: sum of 2 quarters · filed 2026-04-29 | $1.21M derived: sum of 3 quarters · filed 2026-09-04 | $1.89M 10-K · filed 2026-04-29 |
| 2025-10-31 | $457.11K 10-Q · filed 2025-12-11 | $1.02M derived: sum of 2 quarters · filed 2026-09-04 | $1.70M 10-Q · filed 2025-12-11 | $2.19M derived: sum of 4 quarters · filed 2026-09-04 |
| 2025-07-31 | $562.55K 10-Q · filed 2026-09-04 | $1.25M 10-Q · filed 2026-09-04 | $1.74M derived: sum of 3 quarters · filed 2026-09-04 | $2.62M derived: sum of 4 quarters · filed 2026-09-04 |
| 2025-04-30 | $683.43K 10-Q · filed 2026-06-11 | $1.17M derived: sum of 2 quarters · filed 2026-06-11 | $2.05M derived: sum of 3 quarters · filed 2026-06-11 | $2.83M derived: sum of 4 quarters · filed 2026-06-11 |
| 2025-01-31 | $489.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-29 | $1.37M derived: sum of 2 quarters · filed 2026-04-29 | $2.14M derived: sum of 3 quarters · filed 2026-04-29 | $3.12M 10-K · filed 2026-04-29 |
| 2024-10-31 | $880.77K 10-Q · filed 2025-12-11 | $1.65M derived: sum of 2 quarters · filed 2025-12-11 | $2.63M 10-Q · filed 2025-12-11 | $3.19M derived: sum of 4 quarters · filed 2025-12-11 |
| 2024-07-31 | $773.98K 10-Q · filed 2025-09-09 | $1.75M 10-Q · filed 2025-09-09 | $2.31M derived: sum of 3 quarters · filed 2025-09-09 | $2.86M derived: sum of 4 quarters · filed 2025-09-09 |
| 2024-04-30 | $974.53K 10-Q · filed 2025-05-30 | $1.54M derived: sum of 2 quarters · filed 2025-05-30 | $2.09M derived: sum of 3 quarters · filed 2025-05-30 | $2.53M derived: sum of 4 quarters · filed 2025-05-30 |
| 2024-01-31 | $563.37K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-28 | $1.11M derived: sum of 2 quarters · filed 2025-04-28 | $1.56M derived: sum of 3 quarters · filed 2025-04-28 | $1.96M 10-K · filed 2025-04-28 |
| 2023-10-31 | $551.50K 10-Q · filed 2024-12-04 | $996.63K derived: sum of 2 quarters · filed 2024-12-04 | $1.40M 10-Q · filed 2024-12-04 | $1.69M derived: sum of 4 quarters · filed 2024-12-04 |
| 2023-07-31 | $445.12K 10-Q · filed 2024-09-03 | $845.55K 10-Q · filed 2024-09-03 | $1.14M derived: sum of 3 quarters · filed 2024-09-03 | $1.43M derived: sum of 4 quarters · filed 2024-09-03 |
| 2023-04-30 | $400.43K 10-Q · filed 2024-05-31 | $696.26K derived: sum of 2 quarters · filed 2024-05-31 | $986.97K derived: sum of 3 quarters · filed 2024-05-31 | $1.26M derived: sum of 4 quarters · filed 2024-05-31 |
| 2023-01-31 | $295.83K derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-01 | $586.54K derived: sum of 2 quarters · filed 2024-05-01 | $864.41K derived: sum of 3 quarters · filed 2024-05-01 | $982.23K 10-K · filed 2024-05-01 |
| 2022-10-31 | $290.72K 10-Q · filed 2023-12-13 | $568.59K derived: sum of 2 quarters · filed 2023-12-13 | $686.40K 10-Q · filed 2023-12-13 | $936.78K derived: sum of 4 quarters · filed 2023-12-13 |
| 2022-07-31 | $277.87K 10-Q · filed 2023-09-11 | $395.68K 10-Q · filed 2023-09-11 | $646.07K derived: sum of 3 quarters · filed 2023-09-11 | $807.07K derived: sum of 4 quarters · filed 2023-09-11 |
| 2022-04-30 | $117.81K 10-Q · filed 2023-06-09 | $368.20K derived: sum of 2 quarters · filed 2023-06-09 | $529.20K derived: sum of 3 quarters · filed 2023-06-09 | |
| 2022-01-31 | $250.38K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-26 | $411.38K derived: sum of 2 quarters · filed 2023-04-26 | $411.38K 10-K · filed 2023-04-26 | |
| 2021-10-31 | $161.00K 10-Q · filed 2021-12-14 | $161.00K 10-Q · filed 2021-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Conexeu Sciences Inc. (CNXU) | United States | $0.111B | |
| LAKELAND INDUSTRIES INC (LAKE) | United States | $0.104B | -4.21 |
| Safe Pro Group Inc. (SPAI) | United States | $0.090B | |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |
| MYOMO, INC. (MYO) | United States | $0.065B | -2.85 |
| Envoy Medical, Inc. (COCH) | United States | $0.056B | |
| ALPHA PRO TECH LTD (APT) | $0.052B | 13.63 | |
| MILESTONE SCIENTIFIC INC. (MLSS) | United States | $0.036B | -6.85 |
| Lifeward Ltd. (LFWD) | $0.021B | ||
| ENvue Medical, Inc. (FEED) | United States | $0.011B |